Decreased RhoA expression in myocardium of diabetic rats

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 8-9, 2005, Pages 775-783

  Tang, Jiping ^a,b   Fitzgerald, Sharyn M ^a   Boughtman, Brandi N ^a   Cole, Samuel W ^a   Brands, Michael W ^a   Zhang, John H ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Heart; RhoA

Indexed keywords

MESSENGER RNA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; HEART MUSCLE; HEART RATE; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; HEART; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RHOA GTP-BINDING PROTEIN; RNA, MESSENGER; STREPTOZOCIN;

EID: 28944434616     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-077     Document Type: Article

References (41)

1. Aoki, H., Izumo, S., and Sadoshima, J. 1998. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ. Res. 82(6): 666-676.
2. Brands, M.W., and Fitzgerald, S.M. 1998. Acute endothelium-mediated vasodilation is not impaired at the onset of diabetes. Hypertension, 32(3): 541-547.
3. Brownlee, M., Vlassara, H., and Cerami, A. 1984. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101(4): 527-537.
4. Chappell, J., Golovchenko, I., Wall, K., Stjernholm, R., Leitner, J.W., Goalstone, M., and Draznin, B. 2000. Potentiation of Rho-A-mediated lysophosphatidic acid activity by hyperinsulinemia. J. Biol. Chem. 275(41): 31792-31797.
5. Dai, S., Fraser, H., Yuen, V.G., and McNeill, J.H. 1994. Improved in cardiac function in streptozotocin-diabetic rats by salt loading. Can. J. Physiol. Pharmacol. 72(11): 1288-1293.
6. Dillmann, W.H. 1980. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes, 29(7): 579-582.
7. Fein, F.S., Strobeck, I.E., Malhotra, A., Scheuer, J., and Sonnenblick, E.H. 1981. Reversibility of diabetic cardiomyopathy with insulin in rats. Circ. Res. 49(6): 1251-1261.
8. Fein, F.S., Miller-Green, B., and Sonnenblick, E.H. 1985. Altered myocardial mechanics in diabetic rabbits. Am. J. Physiol. 248(5, Pt. 2): H729-H736.
9. Finkel, T. 1999. Myocyte hypertrophy: the long and winding RhoA'd. J. Clin. Investig. 103(12): 1619-1620.
10. Fitzgerald, S.M., and Brands, M.W. 2000. Nitric oxide may be required to prevent hypertension at the onset of diabetes. Am. J. Physiol. Endocrinol. Metab. 279(4): E762-E768.
11. Gotzsche, O. 1982. Lack of cardiotoxic effect of isoproterenol in streptozotocin diabetic rats: a morphometric effect study of isoproterenol induced fibrosis. Virchows Arch. A Pathol. Anat. Histol. 397(1): 83-91.
12. Gotzsche, O. 1985. Abnormal myocardial calcium uptake in streptozotocin-diabetic rats: evidence for a direct insulin effect on catecholamine sensitivity. Diabetes, 34(3): 287-290.
13. Hirata, K., Kikuchi, A., Sasaki, T., Sasaki, T., Kuroda, S., Kaibuchi, K., et al. 1992. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J. Biol. Chem. 267(13): 8719-8722.
14. Hoshijima, M., Hoshijima, M., Sah, V.P., Wang, Y., Chein, K.R., and Brown, J.H. 1998. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes: involvement of Rho-kinase. J. Biol. Chem. 273(13): 7725-7730.
15. Kim, P., Yoshimoto, Y., Iino, M., Tomio, S., Kirino, T., and Nonomura, Y. 1996. Impaired calcium regulation of smooth muscle during chronic vasospasm following subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 16(2): 334-341.
16. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., et al. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase. Science (Washington, D.C.), 273(5272): 245-248.
17. Kita, Y., Shimizu, M., Sugihara, N., Shimizu, K., Yoshio, H., Shibayama, S., and Takeda, R. 1991. Correlation between histopathological changes and mechanical dysfunction in diabetic hearts. Diabetes Res. Clin. Pract. 11(3): 177-188.
18. Kuwahara, K., Saito, Y., Nakagawa, O., Kishimoto, I., Harada, M., Ogawa, E., et al. 1999. The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat myocytes- possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett. 452(3): 314-318.
19. Litwin, S.E., Raya, T.E., Anderson, P.G., Daugherty, S., and Goldman, S. 1990. Abnormal cardiac function in the streptozotocin-diabetic rat: changes inactive and passive properties of the left ventricle. J. Clin. Investig. 86(2): 481-488.
20. Mackay, D.J., and Hall, A. 1998. Rho GTPases. J. Biol. Chem. 273(33): 20685-20688.
21. Malhotra, A., and Sanghi, V. 1997. Regulation of contractile proteins in diabetic heart. Cardiovasc. Res. 34(1): 34-40.
22. Miyagi, Y., Carpenter, R., Meguro, T., Parent, A., and Zhang, J. 2000. Up-regulation of RhoA and Rho kinases in rat double hemorrhage model. J. Neurosurg. 93(3): 471-476.
23. Modrak, J. 1980. Collagen metabolism in the myocardium from streptozotocin-diabetic rats. Diabetes, 29(7): 547-550.
24. Narumiya, S. 1996. The small GTPase Rho: cellular functions and signal transduction. J. Biochem. 120(2): 215-228.
25. Niiro, N., Nishimura, J., Sakihara, C., Nakano, H., Kanaide, H. 1997. Up-regulation of RhoA and Rho-kinase mRNAs in the rat myometrium during pregnancy. Biochem. Biophys. Res. Commun. 230(2): 356-359.
26. Noda, M., Yasuda, F.C., Moriishi, K., Kato, T., Okuda, T., Kurokawa, K., and Takuwa, Y. 1995. Involvement of rho in GTPgS-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett. 367(3): 246-250.
27. q and α1-adrennergic receptor signaling in cardiomyocytes: dissociation of Ras and Rho pathways. J. Biol. Chem. 271(49): 31185-31195.
28. Sah, V.P., Minamisawa, S., Tam, S.P., Wu, T.H., Dorn, G.W. II, Ross, J., Jr., et al. 1999. Cardiac specific overexpression of RhoA results in sinus and atriaoventricular nodal dysfunction and contractile failure. J. Clin. Investig. 103(12): 1627-1634.
29. Sandu, O.A., Ragolia, L., Begum, N. 2000. Diabetes in the Goto-Kakizaki Rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes, 49(12): 2178-2189.
30. Seasholtz, T.M., Mousumi, M., Kaplan, D.D., and Brown, J.H. 1999. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ. Res. 84(10): 1186-1193.
31. Shimabukuro, M., Shizato, T., Nagamine, F., Murakami, K., and Takasu, N. 1995. Impaired mechanical response to calcium of diabetic rat hearts: reversal by nifedipine treatment. J. Cardiovasc. Pharmacol. 26(3): 495-502.
32. Shimamoto, Y., Shimamoto, H., Kwan, C.Y., and Daniel, E.E. 1993. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am. J. Physiol. 264: H1300-H1306.
33. Shimokawa, H., Seto, M., Katsumata, N., Amano, M., Kozai, T., Yamawaki, T., et al. 1999. Rho-kinase mediated pathway induces enhanced myosin light chain phosphorylation in the swine model of coronary artery spasm. Cardiovasc. Res. 43(4): 1029-1039.
34. Siebert, P.D., and Larrick, J.W. 1992. Competitive PCR. Nature (London), 359(6395): 557-558.
35. Siebert, P.D., and Larrick, J.W. 1993. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques, 14(2): 244-249.
36. Standaert, M., Bandyopadhyay, G., Galloway, L., Ono, Y., Mukai, H., and Farese, R. 1998. Comparative effects of GTPγS and insulin on the activation of Rho, phosphatidylinositol 3-kinase, and protein kinase N in rat adipocytes. J. Biol. Chem. 273(13): 7470-7477.
37. Thorburn, J., Xu, S., and Thorburn, A. 1997. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J. 16(8): 1888-1900.
38. Tomlinson, K., Gardiner, S., Hebden, R., and Bennett, T. 1992. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol. Rev. 44(1): 103-149.
39. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., et al. 1997. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (London), 389(6654): 990-994.
40. Verma, S., and McNeill, J.H. 1994. Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts. Am. J. Physiol. 266(2, Pt. 2): H714-H719.
41. Wang, S.M., Tsai, Y.J., Jiang, M.J., and Tseng, Y.Z. 1997. Studies on the function of RhoA protein in cardiac myofibrillogenesis. J. Cell Biochem. 66(1): 43-53.